Literature DB >> 16134194

Perturbations induced by synthetic peptides from hepatitis G virus structural proteins in lipid model membranes: a fluorescent approach.

Cristina Larios1, Jorge Casas, Concepció Mestres, Isabel Haro, M Asunción Alsina.   

Abstract

The name HGV/GBV-C remains as an acronym for hepatitis G virus (HGV) and GB virus-C (GBV-C), strain variants of this enveloped RNA virus independently but simultaneously discovered in 1995. Nowadays there is no evidence that it causes hepatitis in humans either during initial infection or after long-term carriage, but it has been recently related with HIV regarding the inhibition of progression to AIDS. The overall genomic organization of HGV/GBV-C is similar to that of hepatitis C virus (HCV) and other members of the Flavivirus family in Hepacivirus genus. Although a stretch of conserved, hydrophobic amino acids within the envelop glycoprotein of HCV has been proposed as the virus fusion peptide, the mode of entry of GBV-C/HGV into target cells is at present unknown. In the present work, sequences derived from the structural E2-protein of HGV/GBV-C have been selected by means of semiempirical methods and then synthesized manually following solid-phase methodologies. Their ability to induce perturbations in model membranes has been analysed by measuring the penetration of such peptides in lipid monolayers and by a series of experiments based on tryptophan peptide fluorescence emission spectra. Besides, release of vesicular contents to the medium was monitored by the ANTS/DPX assay. The membrane destabilization properties of these peptides was found very related with the length of the sequence. Copyright 2005 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16134194     DOI: 10.1002/bio.850

Source DB:  PubMed          Journal:  Luminescence        ISSN: 1522-7235            Impact factor:   2.464


  4 in total

1.  GB virus type C envelope protein E2 elicits antibodies that react with a cellular antigen on HIV-1 particles and neutralize diverse HIV-1 isolates.

Authors:  Emma L Mohr; Jinhua Xiang; James H McLinden; Thomas M Kaufman; Qing Chang; David C Montefiori; Donna Klinzman; Jack T Stapleton
Journal:  J Immunol       Date:  2010-09-08       Impact factor: 5.422

Review 2.  GB virus type C interactions with HIV: the role of envelope glycoproteins.

Authors:  Emma L Mohr; Jack T Stapleton
Journal:  J Viral Hepat       Date:  2009-09-15       Impact factor: 3.728

3.  A novel genotype of GB virus C: its identification and predominance among injecting drug users in Yunnan, China.

Authors:  Yue Feng; Wenhua Zhao; Yuemei Feng; Jiejie Dai; Zheng Li; Xiaoyan Zhang; Li Liu; Jie Bai; Huatang Zhang; Ling Lu; Xueshan Xia
Journal:  PLoS One       Date:  2011-10-06       Impact factor: 3.240

4.  The structural dynamics of the flavivirus fusion peptide-membrane interaction.

Authors:  Ygara S Mendes; Nathalia S Alves; Theo L F Souza; Ivanildo P Sousa; M Lucia Bianconi; Rafael C Bernardi; Pedro G Pascutti; Jerson L Silva; Andre M O Gomes; Andréa C Oliveira
Journal:  PLoS One       Date:  2012-10-19       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.